Exact Sciences Corp Q2 2021 Earnings Call Summary - Thomson StreetEvents

Exact Sciences Corp Q2 2021 Earnings Call Summary

Exact Sciences Corp Q2 2021 Earnings Call Summary - Thomson StreetEvents
Exact Sciences Corp Q2 2021 Earnings Call Summary
Published Jul 28, 2021
21 pages (11327 words) — Published Jul 28, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of EXAS.OQ earnings conference call or presentation 28-Jul-21 9:00pm GMT

  
Brief Excerpt:

...A. Details: Tested 850,000 people with: 1. Cologuard. a. b. Oncotype DX. c. COVID test. 2. Team remained unwavering in their dedication to Co.'s mission and delivered record results for Cologuard and Oncotype. Team delivered in spite of limited sales force and in-person wellness visits due to COVID. a. 3. Co. is a leader in advanced cancer diagnostics because of its people, capabilities, scientific platform and powerful brands. Will transform cancer care with Co.'s strong foundation in: a. i. Screening. ii. Precision Oncology. iii. Pipeline of innovative tests. 4. Has relentless focus on creating a great co. culture with the best team. 5. Co. is inspired to achieve its mission of cancer eradication. a. Because of this passion and engagement, Co. was recently certified as Great Place to Work for the third year in a row....

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Exact Sciences Corp
Ticker
EXAS.OQ
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kyle Alexander Mikson - Canaccord Genuity Corp., Research Division - Analyst : So on this $13 million headwind in the second half, in your opinion, is that weighted more towards the wellness visits or the, I guess, sales force access? I just wanted to know how we should kind of perceive those factors going forward? And if you could also like similarly rank order maybe some of the drivers of upside that give you some more optimism whether that's Epic or rescreening, et cetera, that would be helpful. And then just one timing question on the MRD clinical validation data. Is there any timing you could kind of tell us to better understand how to think about that as well?

Table Of Contents

Exact Sciences Corp Q3 2021 Earnings Call Summary – 2021-11-02 – US$ 54.00 – Edited Brief of EXAS.OQ earnings conference call or presentation 2-Nov-21 9:00pm GMT

Exact Sciences Corp Q3 2021 Earnings Call Transcript – 2021-11-02 – US$ 54.00 – Edited Transcript of EXAS.OQ earnings conference call or presentation 2-Nov-21 9:00pm GMT

Exact Sciences Corp at Robert W Baird Global Healthcare Conference (Virtual) Transcript – 2021-09-15 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 15-Sep-21 4:15pm GMT

Exact Sciences Corp at Wells Fargo Virtual Healthcare Conference Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 9-Sep-21 2:40pm GMT

Exact Sciences Corp Q2 2021 Earnings Call Transcript – 2021-07-28 – US$ 54.00 – Edited Transcript of EXAS.OQ earnings conference call or presentation 28-Jul-21 9:00pm GMT

Exact Sciences Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-09 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 9-Jun-21 6:10pm GMT

t Sciences Corp at Jefferies Healthcare Conference (Virtual) Transcript – 2021-06-02 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 2-Jun-21 2:00pm GMT

Exact Sciences Corp at UBS Global Healthcare Virtual Conference Transcript – 2021-05-25 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 25-May-21 8:00pm GMT

Exact Sciences Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript – 2021-05-12 – US$ 54.00 – Edited Transcript of EXAS.OQ presentation 12-May-21 5:15pm GMT

Exact Sciences Corp Q1 2021 Earnings Call Summary – 2021-05-04 – US$ 54.00 – Edited Brief of EXAS.OQ earnings conference call or presentation 4-May-21 9:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Exact Sciences Corp Q2 2021 Earnings Call Summary" Jul 28, 2021. Alacra Store. May 17, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Exact-Sciences-Corp-Earnings-Call-B14919979>
  
APA:
Thomson StreetEvents. (2021). Exact Sciences Corp Q2 2021 Earnings Call Summary Jul 28, 2021. New York, NY: Alacra Store. Retrieved May 17, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Exact-Sciences-Corp-Earnings-Call-B14919979>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.